KR920021986A - 유도성 발광을 활용하는 분석방법 - Google Patents
유도성 발광을 활용하는 분석방법 Download PDFInfo
- Publication number
- KR920021986A KR920021986A KR1019920008623A KR920008623A KR920021986A KR 920021986 A KR920021986 A KR 920021986A KR 1019920008623 A KR1019920008623 A KR 1019920008623A KR 920008623 A KR920008623 A KR 920008623A KR 920021986 A KR920021986 A KR 920021986A
- Authority
- KR
- South Korea
- Prior art keywords
- medium
- analyte
- sbp
- source
- chemiluminescent compound
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/971—Capture of complex after antigen-antibody reaction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/829—Liposomes, e.g. encapsulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 비타민 B12에 대한 분석 결과의 그래프 설명이다.
제2도는 디그옥신 (digoxin)에 대한 분석 결과의 그래프 설명이다.
제3도는 본 발명에 따른 HCG에 대한 분석 결과의 그래프 설명이다.
Claims (15)
- 분석물을 함유하는 것으로 생각되는 매질을 내재적 준안전성 종 (Speses) (이는 상기 매질중에서 확산 가능하며, 분석물의 존재로 인하여 상기의 내재적 준안정성 종에 근접한 상기 매질중의 물질과 바람직하게 반응할 수 있다)을 형성하도록 처리하고, 상기의 내재적 준안정성 종이 상기 물질과 반응(이의 반응을 상기 매질중의 분석물의 양을 나타낸다)했는가를 측정함을 특징으로 하여, 분석물을 측정하는 방법.
- 분석물을 함유하는 것으로 생각되는 매질을 (1) 특이적 결합쌍(sbp)원과 결합된 광감작제 및 (2) sbp원과 결합된 화학적 발광 화합물과 배합(여기에서, 광감작제를 활성화시키는 경우 화학적발광 화합물로부터 방사되는 빛의 양은 상기 매질중의 분석물의 양과 관련된다)함을 개선점으로 하여, 상기 매질을 분석물이 존재하는 경우 특이적 결합상 (specific binding pair ; sbp) 컴플렉스를 형성하도록 처리하고, 컴플렉스가 형성되었는가를 측정하는 단계를 특징으로 하여, 액체 매질중의 분석물을 검정하는 방법.
- 분석물 함유하는 것으로 생각되는 매질을, 분석물에 존재하는 경우 광감작제에 의해 발생되는 싱글렛(singlet)산소가 화학적발광 화합물을 활성화시킨 후 연속하여 빛을 발한 수 있도록 분석물로 인해 광감작제 및 화학적 발광 화합물을 인접되게 되는 조건하에서 처리하고, 빛 (이의 양은 상기 매질중의 분석물의 양과 관련된다)를 측정함을 특징으로 하여, 분석물을 측정하는 방법.
- 제3항에 있어서, 화학적발광 화합물이 올레핀 그룹 및 올레핀 그룹과 결합한 하나 이상의 전자 공여 치환체를 포함하는 방법.
- 제3항에 있어서, 화학적발광 화합물이 p-알킬리덴-N-메틸 아크리단, 에놀에테르 및 에나민으로 이루어진 그룹중에서 선택되는 방법.
- 제3항에 있어서, 적어도 광감작제 또는 화학적발광 화합물이 표면을 갖는 현탁성 입자와 결합되는 방법.
- 제3항에 있어서, 표면이 또한 근접하게 되고 현탁성 입자상에 있으며, 입자가 라텍스 입자, 지질 이중층, 오일 소적, 실리카 입자, 금속 졸 및 염료 미소결정으로 이루어진 그룹중에서 선택되는 방법.
- 제3항에 있어서, 광감작제가 메틸렌 블루, 로즈 벤갈, 포피린 및 프랄로시아닌으로 이루어진 그룹중에서 선택된 염료인 방법.
- 제3항에 있어서, 광감작제 및 화학적발광 화합물 각각이 이와 결합된 특이적 결합쌍(sbp)원을 갖고, sbp이 독립적으로 리간드, 수용체, 폴리뉴클레오타이드 및 폴리뉴클레오타이드 결합제로 이루어진 그릅중에서 선택되는 방법.
- (a) (1) 분석물을 함유하는 것으로 생각되는 매질, (2) 여기 상태에서 산소를 싱글렛 상태로 합성화시킬 수 있는 광감작제(이는 특이적 결합쌍(sbP)원과 결합된다), 및 (3) 화학적발광 화합물을 갖는 현탁성 입자 물질(이는 이에 결함된 sbP원을 갖는다)을 배합하고, (b) 배합물을 광감작제가 여기하도록 광으로 처리하며, (c) 매질로부터 방사되는 발광의 양(이는 매질중의 분석물의 양에 관련된다)에 대해 배합물을 조사함을 특징으로 하여, 분석물을 측정하는 방법.
- (a) (1) 분석물을 함유하는 것으로 생가되는 매질, (2) 제1sbp원과 결합된 광감작제 및 제2spb원과 결합된 화학적발광 화합물을 배합하고, (b) 배합물을 광감작제가 여기하도록 광으로 처리하며, (c) 매질로부터 발사되는 발광의 양(이는 매질중의 분석물의 양에 관련된다)에 대해 배합물을 조사함을 특징으로 하여, 분석물을 측정하는 방법.
- (a) (1) 분석물을 함유하는 것으로 생각되는 샘플, (2) 혼입된 화학적발광 화합물을 갖는 제1 현탁성 입자(이는 spb원이 결합되어 있다), 및 (3) 산소를 이의 싱글렛 상태로 활성화시킬 수 있는 광감작제가 혼입된 제2현탁성 입자(이는 특이적 결함쌍(sbp)원이 결합되어 있다)를 수성 매질중에서 배합하고, (b) 매질을 싱글렛 상태의 산소를 생성하도록 조사하며, (C) 매질로부터 방사되는 발광의 양(이는 매질중의 분석물의 양에 관련된다)을 측정함을 특징으로 하여, 분석물을 측정하는 방법.
- 제1sbp원과 결합된 화학적발광 화합물 및 여기 상태에서 산소를 이의 싱글렛 상태로 활성화시킬 수 있는, 제2 sbp원과 결합된 광감작제를 패키지형 배합물로 포함하는 키트.
- 제13항에 있어서, 패키지형 배합물이 (a) 화학적발광 화합물을 포함하는 현탁성 입자(이는 특이적 결합쌍(sbp)원이 결합되어 있다)를 포함하는 조성물, 및 (2) 상기 조성물에는 포함되지 않으며, 상기 상태에서 산소를 이의 싱글렛 상태로 활성화시킬 수 있는 광감작제를 포함하는 키트.
- 제14항에 있어서, 조성물이 광감작제를 포함하는 제2현탁성 입자(이는 sbp원이 결함되어 있다)를 포함하는 키트.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/704569 | 1991-05-22 | ||
US07/704,569 US6251581B1 (en) | 1991-05-22 | 1991-05-22 | Assay method utilizing induced luminescence |
Publications (2)
Publication Number | Publication Date |
---|---|
KR920021986A true KR920021986A (ko) | 1992-12-19 |
KR100246650B1 KR100246650B1 (en) | 2000-04-01 |
Family
ID=24830050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920008623A KR100246650B1 (en) | 1991-05-22 | 1992-05-21 | Assay methods utilizing induced luminescence |
Country Status (6)
Country | Link |
---|---|
US (2) | US6251581B1 (ko) |
KR (1) | KR100246650B1 (ko) |
FI (1) | FI922309A (ko) |
MX (1) | MX9202439A (ko) |
NO (1) | NO922009L (ko) |
TW (1) | TW205094B (ko) |
Families Citing this family (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578498A (en) * | 1991-05-22 | 1996-11-26 | Behringwerke Ag | Metal chelate containing compositions for use in chemiluminescent assays |
GB9425138D0 (en) * | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
DE69722918D1 (de) * | 1996-02-19 | 2003-07-24 | Schaffer Moshe | Photoempfindliche zusammensetzung |
US6420135B1 (en) * | 1996-10-31 | 2002-07-16 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
ATE239912T1 (de) * | 1997-08-01 | 2003-05-15 | Presens Prec Sensing Gmbh | Verfahren und vorrichtung zur referenzierung von fluoreszenzintensitätssignalen |
US6649362B2 (en) * | 1997-09-08 | 2003-11-18 | Medvet Science Pty. Ltd. | Screening method for an agent having an effect on a sphingosine kinase signaling pathway |
US6322980B1 (en) | 1999-04-30 | 2001-11-27 | Aclara Biosciences, Inc. | Single nucleotide detection using degradation of a fluorescent sequence |
US6514700B1 (en) * | 1999-04-30 | 2003-02-04 | Aclara Biosciences, Inc. | Nucleic acid detection using degradation of a tagged sequence |
US6627400B1 (en) | 1999-04-30 | 2003-09-30 | Aclara Biosciences, Inc. | Multiplexed measurement of membrane protein populations |
US7001725B2 (en) | 1999-04-30 | 2006-02-21 | Aclara Biosciences, Inc. | Kits employing generalized target-binding e-tag probes |
US6673550B2 (en) * | 1999-04-30 | 2004-01-06 | Aclara Biosciences, Inc. | Electrophoretic tag reagents comprising fluorescent compounds |
US7105310B1 (en) * | 2000-07-19 | 2006-09-12 | California Institute Of Technology | Detection of biomolecules by sensitizer-linked substrates |
AU6115300A (en) * | 1999-07-19 | 2001-02-05 | California Institute Of Technology | Detection of biomolecules by sensitizer-linked substrates |
US7160735B2 (en) * | 2000-04-28 | 2007-01-09 | Monogram Biosciences, Inc. | Tagged microparticle compositions and methods |
US7771929B2 (en) * | 2000-04-28 | 2010-08-10 | Monogram Biosciences, Inc. | Tag library compounds, compositions, kits and methods of use |
US20030207300A1 (en) * | 2000-04-28 | 2003-11-06 | Matray Tracy J. | Multiplex analytical platform using molecular tags |
US7537938B2 (en) * | 2000-04-28 | 2009-05-26 | Monogram Biosciences, Inc. | Biomarker detection in circulating cells |
US6632606B1 (en) | 2000-06-12 | 2003-10-14 | Aclara Biosciences, Inc. | Methods for single nucleotide polymorphism detection |
US7186568B1 (en) * | 2000-06-26 | 2007-03-06 | Lumigen Inc. | Electrochemiluminescence from acridan compounds |
DE10064827A1 (de) * | 2000-12-22 | 2002-06-27 | Dade Behring Marburg Gmbh | Nachweisverfahren |
WO2002076499A2 (en) * | 2001-03-23 | 2002-10-03 | Aphton Corporation | Combination treatment of pancreatic cancer |
US20090191232A1 (en) * | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
HUP0501021A3 (en) | 2001-05-21 | 2006-06-28 | Aclara Biosciences Inc Mountai | Methods and compositions for analyzing proteins |
CZ20033143A3 (en) * | 2001-05-21 | 2004-04-14 | Aclara Biosciences, Inc. | Methods and compositions for analyzing proteins |
AU2002344221A1 (en) * | 2001-05-26 | 2002-12-09 | Aclara Biosciences, Inc. | Catalytic amplification of multiplexed assay signals |
CA2448719A1 (en) * | 2001-06-09 | 2002-12-19 | Glsynthesis Inc. | Lipid structures and uses thereof |
US7045311B2 (en) * | 2001-10-25 | 2006-05-16 | Monogram Biosciences, Inc. | Whole cell assay systems for cell surface proteases |
JP2005538929A (ja) | 2002-01-16 | 2005-12-22 | ダイナル バイオテック エイエスエイ | 単一サンプルからの核酸及びタンパク質の単離方法 |
KR20040108655A (ko) * | 2002-03-05 | 2004-12-24 | 아클라라 바이오사이언시스 인코퍼레이티드 | 막-결합된 민감제를 사용하는 복합 분석법 |
WO2003085374A2 (en) * | 2002-04-02 | 2003-10-16 | Aclara Biosciences, Inc. | Multiplexed assays using electrophoretically separated molecular tags |
US20030199603A1 (en) * | 2002-04-04 | 2003-10-23 | 3M Innovative Properties Company | Cured compositions transparent to ultraviolet radiation |
US20040229293A1 (en) * | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | Surface receptor complexes as biomarkers |
US7402397B2 (en) * | 2002-05-21 | 2008-07-22 | Monogram Biosciences, Inc. | Detecting and profiling molecular complexes |
US20040229294A1 (en) * | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | ErbB surface receptor complexes as biomarkers |
US20040229380A1 (en) * | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | ErbB heterodimers as biomarkers |
US7105308B2 (en) | 2002-07-25 | 2006-09-12 | Monogram Biosciences, Inc. | Detecting receptor oligomerization |
US20040229299A1 (en) * | 2002-05-21 | 2004-11-18 | Badal M. Youssouf | Intracellular complexes as biomarkers |
US20050221349A1 (en) * | 2002-05-30 | 2005-10-06 | Stuart Wilson | Methods of detecting target molecules and molecular interactions |
US20040175765A1 (en) * | 2002-07-05 | 2004-09-09 | Sharat Singh | Cell-screening assay and composition |
WO2004010842A2 (en) * | 2002-07-26 | 2004-02-05 | Aclara Biosciences, Inc. | Lipophilic electrophoretic probes |
US20040091850A1 (en) * | 2002-11-08 | 2004-05-13 | Travis Boone | Single cell analysis of membrane molecules |
GB0229287D0 (en) * | 2002-12-16 | 2003-01-22 | Dna Res Innovations Ltd | Polyfunctional reagents |
US6900058B2 (en) * | 2003-03-11 | 2005-05-31 | Bionostics, Inc. | Control solution for photometric analysis |
WO2004088326A2 (en) * | 2003-03-28 | 2004-10-14 | Aphton Corporation | Gastrin hormone immunoassays |
US7402398B2 (en) * | 2003-07-17 | 2008-07-22 | Monogram Biosciences, Inc. | Measuring receptor homodimerization |
US20050019939A1 (en) * | 2003-07-25 | 2005-01-27 | Dale Spall | Combination marker for liquids and method identification thereof |
CA2535510C (en) * | 2003-08-11 | 2013-10-15 | Monogram Biosciences, Inc. | Detecting and profiling molecular complexes |
US20050130246A1 (en) * | 2003-10-27 | 2005-06-16 | Hossein Salimi-Moosavi | Detecting human anti-therapeutic antibodies |
US20050112586A1 (en) * | 2003-11-24 | 2005-05-26 | Roland Janzen | Method and composition for stabilizing liquid reagents |
CA2547351A1 (en) * | 2003-12-01 | 2005-07-07 | Dade Behring Marburg Gmbh | Homogeneous detection method |
US20050118727A1 (en) * | 2003-12-01 | 2005-06-02 | Carsten Schelp | Conjugates and their use in detection methods |
EP1730193A2 (en) * | 2004-03-29 | 2006-12-13 | Receptor Biologix, Inc. | Monoclonal antibodies to gastrin hormone |
US20050272108A1 (en) * | 2004-05-21 | 2005-12-08 | Bhanu Kalra | Stabilized two component system for chemiluminescent assay in immunodiagnostics |
US7316910B2 (en) * | 2004-06-03 | 2008-01-08 | Kinase Scientific, Llc | Rapid test for hemolytic streptococcus |
JP4786656B2 (ja) * | 2004-06-09 | 2011-10-05 | パーキンエルマー エルエーエス,インク. | シデロホアおよび関連組成物を使用する標的分子検出の方法 |
WO2006032980A1 (en) * | 2004-09-22 | 2006-03-30 | Receptor Biologix, Inc. | Monoclonal antibolies to progastrin |
US7939267B2 (en) * | 2004-11-04 | 2011-05-10 | Laboratory Corporation Of America Holdings | Detection of activation of endothelial cells as surrogate marker for angiogenesis |
US7682839B2 (en) * | 2005-03-14 | 2010-03-23 | Lumigen, Inc. | Methods using novel chemiluminescent labels |
US20060205094A1 (en) * | 2005-03-14 | 2006-09-14 | Lumigen, Inc. | Methods using novel chemiluminescent labels |
US20060281104A1 (en) * | 2005-06-13 | 2006-12-14 | Macevicz Stephen C | Leuco dye particles and uses thereof |
US7919242B2 (en) * | 2005-06-30 | 2011-04-05 | Roche Molecular Systems, Inc. | Light emission modifiers and their uses in nucleic acid detection, amplification and analysis |
US20070037174A1 (en) * | 2005-08-12 | 2007-02-15 | Rampal Jang B | Chemiluminescent generated fluorescent labeling |
TWI273667B (en) * | 2005-08-30 | 2007-02-11 | Via Tech Inc | Chip package and bump connecting structure thereof |
EP1994407A4 (en) | 2005-12-30 | 2009-05-20 | Turun Yliopisto | METHOD FOR DETERMINING THE CONCENTRATION, LOAD OR SIZE UNIT OF A SUBSTANCE |
US7799534B2 (en) * | 2006-05-09 | 2010-09-21 | Beckman Coulter, Inc. | Nonseparation assay methods |
US7732153B2 (en) | 2006-05-09 | 2010-06-08 | Beckman Coulter, Inc. | Nonseparation assay methods |
BRPI0711388B1 (pt) * | 2006-05-09 | 2021-02-23 | Beckman Coulter, Inc | método para detectar um analito em uma amostra em um procedimento de ensaio |
BRPI0717416A2 (pt) | 2006-09-21 | 2013-11-12 | Prometheus Lab Inc | Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo |
US9146233B2 (en) * | 2006-11-13 | 2015-09-29 | Perkinelmer Health Sciences, Inc. | Detecting molecular interactions by fluorescence resonance energy transfer on a solid-phase support |
EP2109689A4 (en) * | 2007-02-07 | 2010-02-10 | Perscitus Biosciences Llc | DETECTION OF THE PROXIMITY OF A MOLECULE |
US7674406B2 (en) * | 2007-06-14 | 2010-03-09 | Bindra Perminder S | Chemiluminescent compositions and methods of making and using thereof |
RU2519647C2 (ru) * | 2007-07-13 | 2014-06-20 | Нестек С.А. | Выбор лекарственных средств для терапии рака легких с помощью матриц на основе антител |
US20100240070A1 (en) * | 2007-11-07 | 2010-09-23 | Beckman Coulter, Inc. | Nonseparation Assay Methods Using Peroxide Generating Enzymes |
CA2711843C (en) * | 2007-12-20 | 2018-11-13 | Laboratory Corporation Of America Holdings | Her-2 diagnostic methods |
CA2716826C (en) | 2008-02-25 | 2017-05-09 | Prometheus Laboratories Inc. | Drug selection for breast cancer therapy using antibody-based arrays |
SG177252A1 (en) | 2008-12-01 | 2012-03-29 | Lab Corp America Holdings | METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95 |
CA2749846C (en) | 2009-01-15 | 2018-08-07 | Laboratory Corporation Of America Holdings | Methods of determining patient response by measurement of her-3 |
WO2010095033A1 (en) | 2009-02-20 | 2010-08-26 | Perkinelmer Biosignal, Inc. | Multiplex assay methods and compositions |
CA2753596A1 (en) * | 2009-02-27 | 2010-09-02 | Beckman Coulter, Inc. | Non separation assays with selective signal inhibitors |
MX2011009019A (es) | 2009-02-27 | 2011-09-29 | Beckman Coulter Inc | Ensayos homogeneos de fase de solucion. |
US9347947B2 (en) * | 2009-03-12 | 2016-05-24 | Siemens Healthcare Diagnostics Inc. | Immunoassays employing non-particulate chemiluminescent reagent |
WO2010121066A2 (en) * | 2009-04-15 | 2010-10-21 | Cornell Research Foundation, Inc. | Silica nanoparticles incorporating chemiluminescent and absorbing active molecules |
US7964119B2 (en) * | 2009-05-12 | 2011-06-21 | Mega Glow, LLC. | Chemiluminescent powders and methods of making and using thereof |
US8658066B2 (en) | 2009-05-12 | 2014-02-25 | Mega Glow, Llc | Chemiluminescent powders and methods of making and using thereof |
ES2627909T3 (es) | 2009-07-15 | 2017-08-01 | Diatech Holdings, Inc. | Selección de fármacos para el tratamiento del cáncer gástrico usando matrices basadas en anticuercuerpos |
TW201113523A (en) * | 2009-08-31 | 2011-04-16 | Mbio Diagnostics Inc | Integrated sample preparation and analyte detection |
US8153442B2 (en) * | 2009-10-21 | 2012-04-10 | Siemens Healthcare Diagnostics Inc. | Stabilization of signal generation in particles used in assays |
US20110306148A1 (en) | 2010-06-14 | 2011-12-15 | Siemens Healthcare Diagnostics Inc. | Composition for use as an assay reagent |
EP2399971A1 (en) | 2010-06-25 | 2011-12-28 | Mega Glow, Inc | Chemiluminescent compositons and methods of making and using thereof |
US8778614B2 (en) | 2010-08-24 | 2014-07-15 | Enzo Life Sciences, Inc. | Assays for detecting modified compounds |
US9995681B2 (en) * | 2010-09-28 | 2018-06-12 | Authentix, Inc. | Determining the quantity of a taggant in a liquid sample |
US9719995B2 (en) | 2011-02-03 | 2017-08-01 | Pierian Holdings, Inc. | Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling |
JP6468838B2 (ja) | 2011-05-19 | 2019-02-13 | ラボラトリー コーポレイション オブ アメリカ ホールディングス | 癌患者の生存可能性を決定するためおよび癌患者における転移可能性を予測するための方法 |
KR101851425B1 (ko) | 2011-09-02 | 2018-04-23 | 네스텍 소시에테아노님 | 치료 효능 결정을 위한 신호 경로 단백질의 프로파일링 |
US8771964B2 (en) | 2012-02-02 | 2014-07-08 | Siemens Healthcare Diagnostics Inc. | Compositions and methods for detection of methadone metabolite |
CN102798725B (zh) * | 2012-08-13 | 2015-03-18 | 沃克(天津)生物科技有限公司 | 血清总IgE测定诊断试剂盒及制备和使用方法 |
US9244083B2 (en) | 2012-11-30 | 2016-01-26 | Siemens Healthcare Diagnostics Inc. | Compositions and methods for detecting vitamin D |
JP6402173B2 (ja) | 2013-04-05 | 2018-10-10 | ラボラトリー コーポレイション オブ アメリカ ホールディングス | Her3の検出に基づく癌の診断、予後予測、および処置を容易にするためのシステムおよび方法 |
US20140308751A1 (en) | 2013-04-12 | 2014-10-16 | Siemens Healthcare Diagnostics Inc. | Assays for Analyte Homologs |
KR101783438B1 (ko) * | 2013-05-06 | 2017-09-29 | 한국과학기술연구원 | 형광 바코드를 이용한 미생물의 구별 방법, 미생물 검출용 조성물 및 키트 |
US9933421B2 (en) * | 2013-08-19 | 2018-04-03 | Catassays | Catalytic marking nanoparticles for ultrasensitive bioassay applications |
US10124072B2 (en) * | 2013-09-18 | 2018-11-13 | Caliper Life Sciences, Inc. | In-vivo reactive species imaging |
CN103837675B (zh) * | 2014-03-07 | 2016-01-13 | 天津市南开医院 | 多组分同时定量分析的均相发光免疫分析方法及其所使用的试剂盒 |
MX2016011809A (es) * | 2014-03-26 | 2017-05-10 | Siemens Healthcare Diagnostics Inc | Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos. |
CN103954776B (zh) * | 2014-05-12 | 2016-05-18 | 武汉生之源生物科技有限公司 | Ngal光激发化学发光检测试剂盒、其制备及使用方法 |
EP3172239A4 (en) | 2014-06-27 | 2017-06-21 | Siemens Healthcare Diagnostics Inc. | Binding partners specific for vitamin d epimers |
CN106661114B (zh) | 2014-06-27 | 2019-01-29 | 西门子医疗保健诊断公司 | 维生素d测定法中对维生素d差向异构体特异性的结合配偶体 |
US10677734B2 (en) * | 2014-09-05 | 2020-06-09 | Thermo Fisher Scientific Oy | Method and apparatus for optical measurement of liquid sample |
WO2017040962A1 (en) * | 2015-09-04 | 2017-03-09 | Pioneer Hi-Bred International, Inc. | Compositions and methods of detecting a substance of interest |
JP2019515252A (ja) | 2016-03-15 | 2019-06-06 | ラボラトリー コーポレイション オブ アメリカ ホールディングス | 細胞間のタンパク質相互作用を評価する方法 |
DK3482210T3 (da) | 2016-07-06 | 2021-07-12 | Prothena Biosciences Ltd | Assay til detektering af totalt og s129-phosphoryleret alpha-synuklein |
EP4252629A3 (en) | 2016-12-07 | 2023-12-27 | Biora Therapeutics, Inc. | Gastrointestinal tract detection methods, devices and systems |
AU2017378398B2 (en) | 2016-12-14 | 2023-02-02 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices |
EP3554346B1 (en) | 2016-12-14 | 2024-01-31 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with an immunosuppressant |
US20200315540A1 (en) | 2016-12-14 | 2020-10-08 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an il-1 inhibitor |
US11426566B2 (en) | 2016-12-14 | 2022-08-30 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a TLR modulator |
CN116712540A (zh) | 2016-12-14 | 2023-09-08 | 比奥拉治疗股份有限公司 | 使用整联蛋白抑制剂治疗胃肠道疾病 |
BR112019011689A2 (pt) | 2016-12-14 | 2019-10-22 | Progenity Inc | tratamento de uma doença do trato gastrointestinal com um inibidor de tnf |
CA3045475A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device |
CA3045472A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a smad7 inhibitor |
WO2018112237A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor |
CA3045310A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
US10682602B2 (en) * | 2017-01-19 | 2020-06-16 | National University Of Singapore | Nanofibrous filter |
US11596670B2 (en) | 2017-03-30 | 2023-03-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist |
WO2018183932A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor |
EP4108183A1 (en) | 2017-03-30 | 2022-12-28 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
EP3601531B1 (en) | 2017-03-30 | 2023-06-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with live biotherapeutics |
CA3054159A1 (en) | 2017-03-30 | 2018-10-04 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor |
CA3066756A1 (en) | 2017-06-15 | 2018-12-20 | Cancer Advances Inc. | Compositions and methods for inducing humoral and cellular immunities against tumors and cancer |
JP7365241B2 (ja) | 2017-06-27 | 2023-10-19 | ライフ テクノロジーズ ホールディングス プライベート リミテッド | サンプルの分析方法、分析装置、およびコンピュータプログラム |
WO2019036363A1 (en) | 2017-08-14 | 2019-02-21 | Progenity Inc. | TREATMENT OF GASTROINTESTINAL TRACT DISEASE WITH GLATIRAMER OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
JP7488812B2 (ja) | 2018-05-21 | 2024-05-22 | ケムクリン ダイアグノスティックス (シャンハイ) カンパニー リミテッド | 化学発光免疫分析測定法及び該方法を使用するシステム、試薬キット |
CN110514651A (zh) | 2018-05-21 | 2019-11-29 | 博阳生物科技(上海)有限公司 | 一种化学发光免疫分析测定方法及使用该方法的系统、试剂盒 |
CN112400024B (zh) | 2018-06-01 | 2024-04-09 | 比奥拉治疗股份有限公司 | 用于胃肠道微生物组检测和处理的装置和系统 |
US11320424B2 (en) | 2018-07-13 | 2022-05-03 | 3M Innovative Properties Company | Specific binding chemiluminescent assay |
CN110736739A (zh) * | 2018-07-18 | 2020-01-31 | 博阳生物科技(上海)有限公司 | 一种均相化学发光检测试剂盒及其应用 |
WO2020028110A1 (en) | 2018-07-30 | 2020-02-06 | Siemens Healthcare Diagnostics Inc. | Kits, microfluidics devices, and methods for performing biotin assays |
US20200284807A1 (en) | 2019-03-05 | 2020-09-10 | Victor Manneh | Saturation binding ratiometric assay |
CN111735942A (zh) * | 2020-03-03 | 2020-10-02 | 浙江卓运生物科技有限公司 | 一种均相法化学发光检测方法 |
EP4326437A4 (en) * | 2021-04-21 | 2024-09-11 | Siemens Healthcare Diagnostics Inc | COMPOSITIONS, KITS AND METHODS FOR ANTIMICROBIAL SEROLOGY TESTS USING ANTI-HUMAN IMMUNOGLOBULIN ANTIBODIES |
WO2024163318A1 (en) * | 2023-01-30 | 2024-08-08 | Amgen Inc. | System and method for analyzing antibody co-formulations |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3720622A (en) | 1970-01-02 | 1973-03-13 | American Cyanamid Co | Generation of light from the decomposition of dioxetaneones in the presence of a fluorescer |
US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
US4043792A (en) * | 1974-04-09 | 1977-08-23 | Uniroyal, Inc. | Plant growth regulation using certain substituted 2,3-dihydro-1,4-oxathiins |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4199559A (en) | 1974-08-12 | 1980-04-22 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4383031A (en) | 1975-04-28 | 1983-05-10 | Miles Laboratories, Inc. | Homogeneous chemiluminescent specific binding assay |
US4174384A (en) | 1975-06-30 | 1979-11-13 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
GB1575343A (en) | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
US4529561A (en) | 1978-03-24 | 1985-07-16 | The Regents Of The University Of California | Method for producing liposomes in selected size range |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4233402A (en) | 1978-04-05 | 1980-11-11 | Syva Company | Reagents and method employing channeling |
US4220450A (en) | 1978-04-05 | 1980-09-02 | Syva Company | Chemically induced fluorescence immunoassay |
US4380580A (en) | 1978-04-10 | 1983-04-19 | Miles Laboratories, Inc. | Heterogenous chemiluminescent specific binding assay |
US4193983A (en) | 1978-05-16 | 1980-03-18 | Syva Company | Labeled liposome particle compositions and immunoassays therewith |
AU517292B2 (en) | 1978-06-20 | 1981-07-23 | Syva Co. | Fluorescence quenching system |
US4226993A (en) | 1978-07-24 | 1980-10-07 | Miles Laboratories, Inc. | Amino-functionalized phthalhydrazides |
US4318707A (en) | 1978-11-24 | 1982-03-09 | Syva Company | Macromolecular fluorescent quencher particle in specific receptor assays |
US4576912A (en) | 1978-11-30 | 1986-03-18 | Technicon Instruments Corporation | Fluoroimmunoassaying |
US4261968A (en) | 1979-05-10 | 1981-04-14 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4299916A (en) | 1979-12-26 | 1981-11-10 | Syva Company | Preferential signal production on a surface in immunoassays |
US4483921A (en) | 1981-01-12 | 1984-11-20 | Collaborative Research, Inc. | Immunoassay with antigen or antibody labeled liposomes sequestering enzyme |
US4650770A (en) | 1981-04-27 | 1987-03-17 | Syntex (U.S.A.) Inc. | Energy absorbing particle quenching in light emitting competitive protein binding assays |
CA1190838A (en) | 1981-07-17 | 1985-07-23 | Cavit Akin | Homogeneous nucleic acid hybridization diagnostics by non-radiative energy transfer |
CA1180647A (en) | 1981-07-17 | 1985-01-08 | Cavit Akin | Light-emitting polynucleotide hybridization diagnostic method |
US4522803A (en) | 1983-02-04 | 1985-06-11 | The Liposome Company, Inc. | Stable plurilamellar vesicles, their preparation and use |
US4654300A (en) | 1982-04-02 | 1987-03-31 | Syntex (U.S.A.) Inc. | Fluorescent microbead quenching assay |
US4483929A (en) | 1982-05-03 | 1984-11-20 | Liposome Technology Incorporated | Liposomes with glycolipid-linked antibodies |
US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
US4568649A (en) | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
US4588578A (en) | 1983-08-08 | 1986-05-13 | The Liposome Company, Inc. | Lipid vesicles prepared in a monophase |
US4652533A (en) | 1983-04-28 | 1987-03-24 | Pandex Laboratories, Inc. | Method of solid phase immunoassay incorporating a luminescent label |
JPS6036962A (ja) | 1983-08-09 | 1985-02-26 | Toray Ind Inc | 生物学的検査用微粒子 |
EP0144914A3 (en) | 1983-12-12 | 1986-08-13 | Miles Inc. | Hybridization assay employing labeled pairs of hybrid binding reagents |
CA1273552A (en) | 1985-12-23 | 1990-09-04 | Michael J. Heller | Fluorescent stokes shift probes for polynucleotide hybridization assays |
EP0232967B1 (en) | 1986-01-10 | 1993-04-28 | Amoco Corporation | Competitive homogeneous assay |
JPS63502875A (ja) | 1986-03-04 | 1988-10-27 | ケンブリッジ バイオサイエンス コーポレーション | 粒子凝集を用いる核酸検出 |
US5143853A (en) | 1986-06-25 | 1992-09-01 | Trustees Of Tufts College | Absorbance modulated fluorescence detection methods and sensors |
US5254477A (en) | 1986-06-25 | 1993-10-19 | Trustees Of Tufts College | Flourescence intramolecular energy transfer conjugate compositions and detection methods |
US4959182A (en) | 1986-07-17 | 1990-09-25 | Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
US5004565A (en) | 1986-07-17 | 1991-04-02 | The Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
US4978614A (en) | 1988-10-26 | 1990-12-18 | Tropix, Inc. | Method of detecting a substance using enzymatically-induced decomposition of dioxetanes |
BR8707399A (pt) | 1986-07-24 | 1988-09-13 | Quest Systems Inc | Metodo de detectar uma substancia usando decomposicao enzimaticamente induzida de dioxetanos |
US4891324A (en) | 1987-01-07 | 1990-01-02 | Syntex (U.S.A.) Inc. | Particle with luminescer for assays |
US5017473A (en) | 1987-05-26 | 1991-05-21 | Becton, Dickinson And Company | Homogeneous chemiluminescence immunoassay using a light absorbing material |
US4943525A (en) | 1987-11-02 | 1990-07-24 | Bioventures, Inc. | Simultaneous immunoassay for the determination of antigens and antibodies |
US5006309A (en) * | 1988-04-22 | 1991-04-09 | Abbott Laboratories | Immunoassay device with liquid transfer between wells by washing |
JP2681061B2 (ja) | 1988-06-08 | 1997-11-19 | ロンドン・ダイアグノスティック・インコーポレーテッド | 検出可能なシグナルのセンシタイザー誘導発生を利用したアッセイ |
WO1990002205A1 (en) | 1988-08-25 | 1990-03-08 | Angenics, Inc. | Detection of nucleic acid sequences using particle agglutination |
US5061445A (en) * | 1988-11-03 | 1991-10-29 | Igen, Inc. | Apparatus for conducting measurements of electrochemiluminescent phenomena |
US5019496A (en) * | 1989-02-17 | 1991-05-28 | Gerald Oster | Photopolymerization diagnostic test composition and method for immunoassay and nucleic acid assay |
CA2035029C (en) | 1989-09-06 | 2001-12-18 | Brooks Edwards | Synthesis of stable water-soluble chemiluminescent 1,2-dioxetanes and intermediates therefor |
AU6602890A (en) | 1989-10-05 | 1991-04-28 | Exoxemis, Inc. | Haloperoxidase acid optimum chemiluminescence assay system |
DE69125992T2 (de) | 1990-09-14 | 1997-08-21 | Tosoh Corp | Verfahren und Kit für Immunoassay |
EP0515194B1 (en) | 1991-05-22 | 2001-10-31 | Dade Behring Marburg GmbH | Assay methods utilizing induced luminescence |
US5578498A (en) * | 1991-05-22 | 1996-11-26 | Behringwerke Ag | Metal chelate containing compositions for use in chemiluminescent assays |
US5340716A (en) | 1991-06-20 | 1994-08-23 | Snytex (U.S.A.) Inc. | Assay method utilizing photoactivated chemiluminescent label |
EP0653066B1 (en) | 1992-07-31 | 1998-01-28 | BEHRINGWERKE Aktiengesellschaft | Photoactivatable chemiluminescent matrices |
FR2707658B1 (fr) | 1993-07-12 | 1995-11-24 | Prolabo Sa | Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie. |
ATE177842T1 (de) | 1993-09-03 | 1999-04-15 | Behringwerke Ag | Fluoreszenz-sauerstoffkanalisation-immunteste |
-
1991
- 1991-05-22 US US07/704,569 patent/US6251581B1/en not_active Expired - Lifetime
-
1992
- 1992-05-21 KR KR1019920008623A patent/KR100246650B1/ko not_active IP Right Cessation
- 1992-05-21 TW TW081103982A patent/TW205094B/zh not_active IP Right Cessation
- 1992-05-21 FI FI922309A patent/FI922309A/fi unknown
- 1992-05-21 NO NO92922009A patent/NO922009L/no not_active Application Discontinuation
- 1992-05-22 MX MX9202439A patent/MX9202439A/es unknown
-
1995
- 1995-06-06 US US08/471,130 patent/US6406913B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
TW205094B (ko) | 1993-05-01 |
US6251581B1 (en) | 2001-06-26 |
NO922009L (no) | 1992-11-23 |
MX9202439A (es) | 1992-11-01 |
KR100246650B1 (en) | 2000-04-01 |
FI922309A0 (fi) | 1992-05-21 |
FI922309A (fi) | 1992-11-23 |
US6406913B1 (en) | 2002-06-18 |
NO922009D0 (no) | 1992-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920021986A (ko) | 유도성 발광을 활용하는 분석방법 | |
DE69313611T2 (de) | Biospezifisches multiparameter-analyseverfahren | |
Goryacheva et al. | Nanosized labels for rapid immunotests | |
EP0174744B1 (en) | Fluorescent energy transfer with phycobiliproteins | |
FI88340C (fi) | Indirekt kolorimetrisk bestaemning av en analyt i ett prov med hjaelp av ljussignalers foerhaollande | |
Wang et al. | Ascorbic acid induced enhancement of room temperature phosphorescence of sodium tripolyphosphate‐capped Mn‐doped ZnS quantum dots: mechanism and bioprobe applications | |
CA2069145A1 (en) | Assay method utilizing induced luminescence | |
DE69130171D1 (de) | Bestimmung von analyten durch übertragung von fluoreszenzenergie | |
SE8703682D0 (sv) | Homogen bestemningsmetod som utnyttjar affinitetsreaktioner | |
KR900702368A (ko) | 전기화학 발광성 분석 | |
SE454115B (sv) | Homogenfasanalys med lantanidkelat som merksubstans | |
Ding et al. | A SERS-based competitive immunoassay for highly sensitive and specific detection of ochratoxin A | |
Dinh et al. | Room-temperature phosphorescence of several polyaromatic hydrocarbons | |
DE50115064D1 (de) | Sensor zur lumineszenz-optischen bestimmung eines analyten | |
EP0214847A3 (en) | Squarate dye conjugate, process for making it and its use in assay methods and kits | |
CN106908599A (zh) | 检测葡萄酒和葡萄汁中赭曲霉毒素a的免疫层析试纸条 | |
Deshpande | Principles and applications of luminescence spectroscopy | |
DE3855535D1 (de) | Elektrochemilumineszente rhenium-fraktionen und verfahren | |
Díaz et al. | Enhancer effect of fluorescein on the luminol–H2O2–horseradish peroxidase chemiluminescence: energy transfer process | |
Du et al. | Label‐Free, Non‐Derivatization CRET Detection Platform for 6‐Mercaptopurine Based on the Distance‐Dependent Optical Properties of Gold Nanoparticles | |
JP5582745B2 (ja) | 化学発光反応の時間計測による被検出物質の濃度を測定する方法およびそれに使用するキット | |
Blomberg et al. | A dissociative fluorescence enhancement technique for one-step time-resolved immunoassays | |
Legendre Jr et al. | Binding properties of near-IR dyes to proteins and separation of the dye/protein complexes using capillary electrophoresis with laser-induced fluorescence detection | |
JPS62174637A (ja) | 化学発光反応成分検出感度増大法 | |
Liu et al. | Interaction of cetylpyridine bromide with nucleic acids and determination of nucleic acids at nanogram levels based on the enhancement of resonance Rayleigh light scattering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20111114 Year of fee payment: 13 |
|
EXPY | Expiration of term |